Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 4/20 | 0.40 |
| ▸ | LOX | P28300 | 3/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.36 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.35 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.35 |
| ▸ | NOS1 | P29475 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | NOS2 | P35228 | 1/20 | 0.33 |
| ▸ | ELOVL1 | Q9BW60 | 1/20 | 0.33 |
| ▸ | HTR7 | P34969 | 2/20 | 0.33 |
| ▸ | MGMT | P16455 | 1/20 | 0.32 |
| ▸ | PARP1 | P09874 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10674128 | 0.83 | LOXL2 (0.46) | LOXL2LOXHRH3CHRNB2CHRNA4 | |
| SCHEMBL10375013 | 0.81 | LOXL2 (0.47) | LOXL2LOXHRH3CHRNB2CHRNA4 | |
| SCHEMBL10375014 | 0.80 | LOXL2 (0.62) | LOXL2LOXHRH3CHRNB2CHRNA4 | |
| SCHEMBL15015273 | 0.78 | LOXL2 (0.43) | LOXL2LOXHRH3CHRNB2CHRNA4 | |
| SCHEMBL10990098 | 0.77 | HRH3 (0.36) | LOXL2LOXHRH3CHRNB2CHRNA4 | |
| SCHEMBL8920968 | 0.73 | LOXL2 (0.43) | LOXL2LOXHRH3CHRNB2CHRNA4 | |
| SCHEMBL8920977 | 0.73 | LOXL2 (0.43) | LOXL2LOXHRH3CHRNB2CHRNA4 | |
| SCHEMBL15829859 | 0.72 | NOS3 (0.44) | LOXL2LOXHRH3CHRNB2CHRNA4 | |
| SCHEMBL3416236 | 0.72 | NOS1 (0.51) | HRH3CHRNB2CHRNA4NOS1ALDH1A1 | |
| SCHEMBL127990 | 0.71 | LOXL2 (0.43) | LOXL2LOXNOS1ALDH1A1NOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4571398-A | Cytosine derivatives having histamine H2 -antagonist activity | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1986-02-18 | — | — | US | claimed |
| EP-0140466-A2 | Pyrimidinone derivatives, process for their preparation, and their pharmaceutical use | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1985-05-08 | — | — | EP | claimed |
| EP-0180298-B1 | PYRIMIDINE COMPOUNDS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1991-09-25 | — | — | EP | disclosed |
| EP-0134096-B1 | AMINOPYRIMIDINONE DERIVATIVES AS HISTAMINE H2-ANTAGONISTS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1989-02-01 | — | — | EP | disclosed |
| US-4738969-A | Substituted aminopyridones and aminoquinolones having histamine H2 -receptor blocking activity | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1988-04-19 | — | — | US | disclosed |
| US-4694008-A | HISTAMINE H2-ANTAGONISTS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1987-09-15 | — | — | US | disclosed |
| US-4608380-A | HISTAMINE H2-ANTAGONISTS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1986-08-26 | — | — | US | disclosed |
| EP-0180298-A2 | Pyrimidine compounds | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1986-05-07 | — | — | EP | disclosed |
| EP-0172968-A1 | Aminothiadiazine derivatives as histamine H2-antagonists | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1986-03-05 | — | — | EP | disclosed |
| US-4571398-A | Cytosine derivatives having histamine H2 -antagonist activity | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1986-02-18 | — | — | US | disclosed |
| EP-0143630-A2 | Chemical compounds | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1985-06-05 | — | — | EP | disclosed |
| EP-0140466-A2 | Pyrimidinone derivatives, process for their preparation, and their pharmaceutical use | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1985-05-08 | — | — | EP | disclosed |
| EP-0134096-A2 | Aminopyrimidinone derivatives as histamine H2-antagonists | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1985-03-13 | — | — | EP | disclosed |